HHS Recommends Re-Classification of Marijuana as a Schedule III Controlled Substance – A Bellwether for the Future of Cannabis-ness
Health Law Advisor
SEPTEMBER 12, 2023
The DEA has the final authority to reschedule a drug and will now initiate its own review of marijuana, a process that does not have any definitive timeline but could be moved along if determined to be an agency priority. In addition, only certain components of FDA’s eight-factor analysis bind the DEA. heroin, LSD, and ecstasy).
Let's personalize your content